Stocktoria
NEUROONE MEDICAL TECHNOLOGIES Corp NMTC
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2012-11-09
NEUROONE MEDICAL TECHNOLOGIES Corp statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 56.5% | 31.3% | 23.4% | -41.4% | -54.9% |
| Operating margin | -46.5% | -344.3% | -612.3% | -5860.2% | -5735.9% |
| Net margin | -39.6% | -356.7% | -607.4% | -5842.0% | -5584.3% |
| FCF margin | -32.1% | -322.4% | -679.7% | -4553.8% | -4866.7% |
| Return on assets | -33.4% | -229.4% | -146.5% | -78.0% | -125.3% |
| Return on equity | -51.0% | -1498.5% | -189.8% | -104.1% | -151.8% |
| Current ratio | 4.44 | 2.09 | 4.08 | 3.93 | 6.17 |
| Revenue growth | 163.5% | 76.9% | 1040.7% | -3.9% | — |
Source: SEC EDGAR filings · CIK 0001500198 · as of 2025-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.